XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cash, Cash Equivalents and Marketable Investments (Tables)
9 Months Ended
Sep. 30, 2022
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
September 30, 2022CostGainsLossesValue
Cash and cash equivalents$45,880 $— $— $45,880 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows46,580 — — 46,580 
Marketable investments - U.S. Treasury205,282 13 (349)204,946 
Total$251,862 $13 $(349)$251,526 
GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
December 31, 2021CostGainsLossesValue
Cash and cash equivalents$164,164 $— $— $164,164 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows$164,864 $— $— $164,864 
Schedule of Restricted Cash and Cash Equivalents
The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
September 30, 2022CostGainsLossesValue
Cash and cash equivalents$45,880 $— $— $45,880 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows46,580 — — 46,580 
Marketable investments - U.S. Treasury205,282 13 (349)204,946 
Total$251,862 $13 $(349)$251,526 
GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
December 31, 2021CostGainsLossesValue
Cash and cash equivalents$164,164 $— $— $164,164 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows$164,864 $— $— $164,864 
Schedule of Available-for-Sale Securities
The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
September 30, 2022CostGainsLossesValue
Cash and cash equivalents$45,880 $— $— $45,880 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows46,580 — — 46,580 
Marketable investments - U.S. Treasury205,282 13 (349)204,946 
Total$251,862 $13 $(349)$251,526 
GrossGrossFair
AmortizedUnrealizedUnrealizedMarket
December 31, 2021CostGainsLossesValue
Cash and cash equivalents$164,164 $— $— $164,164 
Non-current restricted cash700 — — 700 
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows$164,864 $— $— $164,864 
The following table summarizes the contractual maturities of the Company’s available-for-sale securities, classified as marketable investments, as of September 30, 2022 (in thousands):

September 30, 2022Amount
Due in less than one year$205,282